Enanta Pharmaceuticals, Inc. (ENTA)
NGS · Common · CUSIP 29251M106
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for ENTA and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
29251M106
Market Cap
Large Cap
IPO
3/21/2013 · $14.00/share
Business: Enanta Pharmaceuticals, Inc. is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field.

Company Contact

CEO
Jay R. Luly, Ph.D.
CFO
Paul J. Mellett
Headquarters
500 Arsenal Street, Watertown, MA 02472
Phone
617-607-0800
Fax
617-607-0530
Investor Relations
Jennifer Viera · 617-744-3848 · jviera@enanta.com
General Email
info@enanta.com
SEC EDGAR Filings
View filings »